Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-026637
Filing Date
2014-07-11
Accepted
2014-07-11 20:26:20
Documents
1
Period of Report
2014-07-10

Document Format Files

Seq Description Document Type Size
1 rrd413121.html 4  
1 rrd413121.xml 4 12198
  Complete submission text file 0001181431-14-026637.txt   13702
Mailing Address 61 HARTFORD STREET SAN FRANCISCO CA 94114
Business Address
HASTINGS PAUL J (Reporting) CIK: 0001309702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 14972635

Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations